Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.

Jensen TO, Grandits GA, Jain MK, Murray TA, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens RA, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER, ACTIV-3/TICO Study Group

Open source

DOI
10.1093/infdis/jiad446
Published
2024 Mar 14
Container
The Journal of infectious diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/infdis/jiad446,
  title = {Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.},
  author = {Jensen TO and Grandits GA and Jain MK and Murray TA and Grund B and Shaw-Saliba K and Matthay MA and Abassi M and Ardelt M and Baker JV and Chen P and Dewar RL and Goodman AL and Hatlen TJ and Highbarger HC and Holodniy M and Lallemand P and Laverdure S and Leshnower BG and Looney D and Moschopoulos CD and Mugerwa H and Murray DD and Mylonakis E and Nagy-Agren S and Rehman MT and Rupert A and Stevens RA and Turville S and Weintrob A and Wick K and Lundgren J and Ko ER and ACTIV-3/TICO Study Group},
  year = {2024},
  journal = {The Journal of infectious diseases},
  doi = {10.1093/infdis/jiad446},
  url = {https://doi.org/10.1093/infdis/jiad446}
}

RIS

TY  - JOUR
TI  - Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
AU  - Jensen TO
AU  - Grandits GA
AU  - Jain MK
AU  - Murray TA
AU  - Grund B
AU  - Shaw-Saliba K
AU  - Matthay MA
AU  - Abassi M
AU  - Ardelt M
AU  - Baker JV
AU  - Chen P
AU  - Dewar RL
AU  - Goodman AL
AU  - Hatlen TJ
AU  - Highbarger HC
AU  - Holodniy M
AU  - Lallemand P
AU  - Laverdure S
AU  - Leshnower BG
AU  - Looney D
AU  - Moschopoulos CD
AU  - Mugerwa H
AU  - Murray DD
AU  - Mylonakis E
AU  - Nagy-Agren S
AU  - Rehman MT
AU  - Rupert A
AU  - Stevens RA
AU  - Turville S
AU  - Weintrob A
AU  - Wick K
AU  - Lundgren J
AU  - Ko ER
AU  - ACTIV-3/TICO Study Group
PY  - 2024
JO  - The Journal of infectious diseases
DO  - 10.1093/infdis/jiad446
UR  - https://doi.org/10.1093/infdis/jiad446
ER  - 

APA

TO, J., GA, G., MK, J., TA, M., B, G., K, S., MA, M., M, A., M, A., JV, B., P, C., RL, D., AL, G., TJ, H., HC, H., M, H., P, L., S, L., BG, L., D, L., CD, M., H, M., DD, M., E, M., S, N., MT, R., A, R., RA, S., S, T., A, W., K, W., J, L., ER, K., & Group, A. S. (2024). Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.. The Journal of infectious diseases. https://doi.org/10.1093/infdis/jiad446

Source records